Silvercorp Metals (AMEX:SVM) reported quarterly earnings of $0.08 per share. This is a 11.11 percent decrease over earnings of $0.09 per share from the same period last year.
CorMedix Inc. Announces Publication Of Phase 3 LOCK IT-100 Study Data In The Clinical Journal Of The American Society Of Nephrology
CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced the